Haemonetics completes $550m acquisition
E-mail
|
Print
|
Comments ()
08/02/2012 7:52 AM
Haemonetics Corp., a blood management company based in Braintree, said it has completed the $550 million acquisition of the business assets of the blood collection, filtration, and processing product lines of Pall Corp.
The sales agreement was announced earlier this year.
The combined company is expected to generate greater than $1 billion of revenue in its full fiscal year 2014, Haemonetics said in a press release.
The company also announced that it has entered into a new $525 million credit agreement with a syndicate of lenders led by JPMorgan Chase Bank N.A. and Citibank N.A.
Haemonetics added that it has scheduled a webcast for Thursday morning to discuss its first-quarter earnings.
Chris Reidy can be reached at reidy@globe.com.
MOST E-MAILED »
- Men's Wearhouse ousts founder, pitchman Zimmer - Boston.com
- Cambridge public schools close to mark Islamic holiday
- Jumpshell hopes its social service will help apartment renters elude broker fees
- Hingham Middle School sends principal off with flash mob
- Parents: sibling fights can lead to mental health problems
- Boston is No. 1 on Parenting magazine's 'Best Cities for Families 2012' list: Share your favorite family-friendly aspect of Boston - Parent Buzz - Boston.com
- The backyard pig roast moves indoors
